Unichem Laboratories Limited
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in India, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical in… Read more
Unichem Laboratories Limited (UNICHEMLAB) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.041x
Based on the latest financial reports, Unichem Laboratories Limited (UNICHEMLAB) has a cash flow conversion efficiency ratio of 0.041x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹1.00 Billion) by net assets (₹24.35 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Unichem Laboratories Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Unichem Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Unichem Laboratories Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Unichem Laboratories Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Union Medical Healthcare Limited
PINK:UNHLF
|
0.157x |
|
LX Hausys Ltd Preferred
KO:108675
|
0.096x |
|
Exotic Food Public Company Limited
BK:XO
|
0.107x |
|
Lonyer Fuels
SHG:603003
|
0.026x |
|
Samjin Pharm
KO:005500
|
-0.005x |
|
Ihlas Holding AS
IS:IHLAS
|
-0.030x |
|
Centaurus Metals Limited
OTCQX:CTTZF
|
-0.280x |
|
Ador Welding Limited
NSE:ADORWELD
|
0.013x |
Annual Cash Flow Conversion Efficiency for Unichem Laboratories Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Unichem Laboratories Limited from 2006 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹24.51 Billion | ₹-70.20 Million | -0.003x | -148.34% |
| 2024-03-31 | ₹23.62 Billion | ₹140.00 Million | 0.006x | +116.96% |
| 2023-03-31 | ₹24.35 Billion | ₹-850.91 Million | -0.035x | +64.76% |
| 2022-03-31 | ₹26.18 Billion | ₹-2.60 Billion | -0.099x | -865.91% |
| 2021-03-31 | ₹25.57 Billion | ₹330.99 Million | 0.013x | +65.36% |
| 2020-03-31 | ₹25.31 Billion | ₹198.16 Million | 0.008x | +106.26% |
| 2019-03-31 | ₹26.20 Billion | ₹-3.28 Billion | -0.125x | -198.48% |
| 2018-03-31 | ₹26.80 Billion | ₹-1.12 Billion | -0.042x | -165.23% |
| 2017-03-31 | ₹10.64 Billion | ₹683.42 Million | 0.064x | -45.18% |
| 2016-03-31 | ₹9.55 Billion | ₹1.12 Billion | 0.117x | +30.19% |
| 2015-03-31 | ₹8.68 Billion | ₹780.99 Million | 0.090x | -15.24% |
| 2014-03-31 | ₹8.17 Billion | ₹867.34 Million | 0.106x | -54.90% |
| 2013-03-31 | ₹7.27 Billion | ₹1.71 Billion | 0.236x | +25.38% |
| 2012-03-31 | ₹6.61 Billion | ₹1.24 Billion | 0.188x | +69.17% |
| 2011-03-31 | ₹6.18 Billion | ₹685.87 Million | 0.111x | -51.59% |
| 2010-03-31 | ₹5.63 Billion | ₹1.29 Billion | 0.229x | +8.11% |
| 2009-03-31 | ₹4.84 Billion | ₹1.03 Billion | 0.212x | +24.66% |
| 2008-03-31 | ₹4.12 Billion | ₹700.30 Million | 0.170x | +43.25% |
| 2007-03-31 | ₹4.02 Billion | ₹478.02 Million | 0.119x | -1.64% |
| 2006-03-31 | ₹3.47 Billion | ₹419.28 Million | 0.121x | -- |